Rezolute raises ~$67M through public offering and concurrent private placement

Rezolute, Inc.

Underwriters exercised over-allotment option for 1,786,589 shares at $4.00 each.
Total offering: 13,036,589 shares plus pre-funded warrants for 3.75M shares; gross proceeds ~$67M.
Concurrent private placement of 1.5M shares at $4.00/share for ~$6M in additional gross proceeds.
Net proceeds will fund clinical R&D (RZ358 for hyperinsulinism) and working capital.
Jefferies and Cantor acted as joint book-running managers for the public offering.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.